Skip to content

Functional Brands, Inc. MEHA Payments Of Stock Issuance Costs

Payments Of Stock Issuance Costs at other companies

EyePoint, Inc.
 logo
EyePoint, Inc. EYPT
$297K+119%
Relmada Therapeutics, Inc. logo
Relmada Therapeutics, Inc.RLMD
$65.65K+260%
TRV
Trevi Therapeutics, Inc.TRVI
$0
Rumble, Inc. logo
Rumble, Inc.RUM
$29.43M+32,132%
Diversified Energy
 logo
Diversified Energy DEC
$6M
NovaGold Resources logo
NovaGold ResourcesNG
$0-100%

Other financials

Income statement

See full
Revenue$1.6M+3.5%
Gross profit$961.1K+10.9%
Operating income-$682.8K-2,027%
Net income-$7.0M-5,414%
EPS (diluted)-$0.36-1,700%

Balance sheet

See full
Cash & equivalents$1.1M+401%
Total debt$2.0M
Total equity-$4.5M-3,048%
Total assets$7.2M

Cash flow

See full
Operating cash flow-$424.6K-341%
CapEx$1.0-99.8%
Free cash flow-$2.7M-4,996%

Valuation

See full
Market cap$793.48K-92.8%
Enterprise value$1.72M
P/S0.1×

Profitability

See full
Gross margin53.7%
Operating margin-30.7%
Net margin-90.1%

Returns & leverage

See full
Return on equity275.7%
Debt / equity1.4×
Current ratio1.2×

Where this comes from

Reported directly by Functional Brands, Inc. in its filing.

Tagged under the XBRL concept us-gaap:PaymentsOfStockIssuanceCosts.

The official record: Functional Brands, Inc. ’s 10-K, filed March 27, 2026, on SEC EDGAR. View the filing →

Ask your AI about Functional Brands, Inc. 's payments of stock issuance costs.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Functional Brands, Inc. 's payments of stock issuance costs?
Functional Brands, Inc. (MEHA) reported payments of stock issuance costs of $1.05M in Q4 2025.
What does payments of stock issuance costs mean?
Reflects the direct costs incurred in the process of issuing equity, such as legal, accounting, and underwriting fees. These costs reduce the net proceeds received from capital raises and are capitalized or expensed according to accounting standards. High costs relative to proceeds may indicate inefficiencies in the company's financing activities.